$ALGN

Clove Dental, Align Technology Announce Partnership to Expand Digital Orthodontic Care Across India

Clove Dental, India's largest dental network, has deployed 106 iTero Lumina intraoral scanners nationwide, enhancing its digital dentistry capabilities. The partnership with Align Technology aims to expand access to advanced orthodontic tools, including Invisalign treatment planning, across India. Both companies highlight the initiative's potential to improve patient experiences and bridge the gap in access to advanced dental care.

Original reporting
Published Sep 5, 2026, 9:49 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 6, 2026, 9:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Clove Dental, Align Technology Announce Partnership to Expand Digital Orthodontic Care Across India — source image
Decision brief

The 30-second read

$ALGNBullishLow
01

Why it matters

The deal expands Align's hardware footprint and service revenue in a high‑population market, though the immediate financial impact is limited.

02

Market read

A strategic partnership that may incrementally boost Align's growth narrative without immediate material earnings impact.

03

What to watch

Local competition and the need for extensive dentist training could slow rollout speed.

Relevance 4/10Novelty 3/10Timing: announcement today

Background

Align Technology, a US‑listed provider of Invisalign orthodontic solutions, partners with Clove Dental, India's largest dental network, to enhance digital treatment capabilities.

Company-level read

Ticker impact

$ALGNBullishMedium confidence
Context

Align Technology announced a partnership with Clove Dental to deploy 106 iTero Lumina intraoral scanners across India, expanding its digital orthodontic footprint.

Expected impact

Modest upside pressure on ALGN as investors price in new market exposure.

Evidence & confidence

The partnership opens a high‑growth Indian market, but the scale (106 scanners) is modest relative to Align's global operations.

Market effects

Accelerates adoption of digital orthodontics in India, signaling growth for dental‑tech suppliers.

Boosts Indian dental‑care sector visibility and may attract further foreign tech partnerships.

Shows Align's strategy to expand in emerging markets, modestly affecting its global growth outlook.

Counterpoint

The Indian market may face pricing pressure and regulatory hurdles, limiting upside for Align.

Key entities

  • Align Technology

    US‑listed maker of Invisalign and iTero scanners.

  • Clove Dental

    India's largest multi‑location dental chain.

Related articles

$ALGNLow

Align Tech adds Quentin Blackford to board

Align Technology (ALGN) added Quentin Blackford, CEO of iRhythm Technologies, to its board, expanding it to 11 members. Blackford brings healthcare and digital innovation experience. Director Andrea L. Saia will retire in September 2026, reducing the board to 10 members.

$ALGNMed

Are Wall Street Analysts Bullish on Align Technology Stock?

Align Technology (ALGN), a medical device company, has underperformed the broader market and healthcare sector ETF over the past 52 weeks. Analysts expect its adjusted EPS to grow 10.9% YoY by 2026, with a consensus 'Moderate Buy' rating. The mean price target is $207.07, implying a 30.1% upside. Piper Sandler maintained a 'Buy' rating with a $235 target.

$ALGNMed

Align Technology Prevails in China Patent Infringement Action Against Angelalign

Align Technology said a Jinan Intermediate People’s Court issued a first-instance ruling on Aug. 10, 2026 in a China patent case against Angel. The court found Angel’s MasterForce and ATreat systems infringe Align’s CN113693748B patent and ordered Angel to stop use, manufacturing, and sales, awarding RMB 10 million in damages. Angel can appeal to China’s Supreme People’s Court.

$ALGNMed

Align Technology, Inc.: Align Technology Prevails in China Patent Infringement Action Against Angelalign

Align Technology (Nasdaq: ALGN) said China’s Jinan Intermediate People’s Court ruled in its favor in a patent infringement case against Angelalign’s China subsidiaries. The court found Angel infringed Align’s CN113693748B patent tied to extraction-gap-closure technology, ordering a stop to use and sales in China and awarding RMB 10 million in damages. Angel can appeal.

$DDDMed

3D Printing Financials: 3D Systems, Prodways, and Align Build on Positive Momentum - 3DPrint.com

3D Systems reported Q2 revenue of $94.6M, flat YoY, with healthcare up 6.8% and aerospace/defense and data center infrastructure each growing over 20%. Adjusted EBITDA loss narrowed to $0.8M. It expects Q3 revenue of $96M to $99M. Prodways posted Q2 revenue of €10.5M (+5% YoY) and plans a €20M buyback. Align Technology reported record Q2 revenue of just over $1.05B (+4.3%), with clear aligner revenue up 8.2% and 2026 revenue growth guidance of 3% to 4%.

$ALGNMedAI 9/10

Align Technology (ALGN) Q2 2026 Earnings Call Transcript

Align Technology (ALGN) reported Q2 2026 revenue of $1,056.2 million, up 4.3% y/y, driven by record Clear Aligner volumes and higher ASPs. Clear Aligner revenue rose 8.2% to $870.9 million on 691,785 cases. Systems and Services revenue fell 10.8% to $185.3 million. Q3 revenue guidance is $1.00 to $1.02 billion; full-year growth 3% to 4%.